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General experimental details
All commercially available reagents and solvents were purchased and used as received from Sigma-Aldrich or Alfa-Aesar. Drying of glassware at 115 °C overnight and activation of molecular sieves in a microwave was performed when anhydrous conditions were required. Dichloromethane was distilled over calcium hydride. Reflux reactions were performed with a paraffin oil bath. Flash column chromatography was performed with Grace Silica Gel 60 (40 -63 µm, 230 -400 mesh), with solvent ratios as specified.
All novel compounds listed below are italicised. Spectroscopic data for single enantiomers were identical to those for the racemate.
Melting points were obtained on an Optimelt Automated Melting Point System and reported in degrees Celsius. Optical rotation was recorded on a Perkin Elmer 341 polarimeter with Na lamp (589 nm). Enantioselective normal phase high-performance liquid chromatography was performed on a Waters 500 analytical HPLC pump (Chiralcel OD-H column, 0.5 mL flowrate, 0.5µL injection volume, specified solvent ratios) with a Waters 2487 dual wavelength absorbance detector (set at 254 nm and 270 nm) and a Waters 410 differential refractometer. 1 H and 13 C nuclear magnetic resonance spectroscopy was conducted on either a Bruker
Avance III 500 at a frequency of 500.13 MHz and 125 MHz or a Bruker Avance III 400 at a frequency of 400.13 MHz and 100 MHz, with deuterated solvents (CDCl 3 or MeOD)
used without further purification. Signals are reported in the order chemical shift (ppm downfield with respect to the solvent residual), integration, multiplicity, coupling constants J (in Hertz) and assignments.
Low-resolution mass spectrometry was performed on a Finnigan LCQ mass spectrometer, Infrared spectroscopy was performed on a Bruker Alpha FT-IR spectrometer under transmission mode, with absorbances reported as wave numbers.
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Experimental procedures and characterisation data 2-(4′-Methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, 4 1
To a degassed mixture of 1,2,3,4-tetrahydroisoquinoline (3.00 g, 22.6 mmol, 1.5 eq), ethylene glycol (2.80 g, 2.52 mL, 30.0 mmol, 2.0 eq) and isopropanol (15 mL) were added 4-iodoanisole (3.52 g, 15.0 mmol, 1.0 eq), potassium phosphate tribasic (9.56 g, 30.0 mmol, 2.0 eq) and copper(I) iodide (0.429 g, 1.50 mmol, 0.1 eq) and the resultant suspension was stirred at 80 °C for 24 h. The reaction mixture was diluted with diethyl ether (50 mL) and filtered through a pad of Celite. The solution was diluted with water (100 mL) and extracted into diethyl ether (3 × 100 mL). The combined organic phases were washed with brine (100 mL), dried (MgSO 4 ) and concentrated under reduced pressure. The majority of the product was isolated through recrystallisation from hexane:ethyl acetate (10:1) to give the product as a white solid. The mother liquor from the recrystallisation was purifed by flash column chromatography (hexanes:ethyl acetate 10:1) to give the product as a white solid (combined yield 2.75 g, 76%). mmol, 1.0 eq) in 100 mL MeOH:NH 3 (9:1) was added Raney nickel (0.3 mL slurry, approximately 0.250 g) and the reaction mixture stirred under H 2 (100 psi) for 4 h at rt.
The reaction mixture was filtered through Celite and the volatiles removed under reduced pressure. The residue was diluted with water (50 mL) and extracted into dichloromethane (50 mL). The aqueous phase was extracted with dichloromethane (2 × 50 mL). The combined organic phases were dried (MgSO 4 ) and concentrated under reduced pressure.
The residue was purified by flash column chromatography (95:4.5:0.5 dichloromethane:methanol:ammonia) to give the product as a brown oil (0.594 g, 87%). 
1-(R)-(Aminomethyl)-2-(4′-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, (R)-10a
To 379.23801.
1-(R)-(N-Cyclohexylcarboxamido methyl)-2-(4′-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, (R)-13a
Synthesised from 1-(R)-(aminomethyl)-2-(4′-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline according to the procedure for the racemate in a yield of 98%.
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Spectroscopic data ( 1 H NMR) match those of the racemate.
. Analysis of the sample by enantioselective HPLC indicated enantiopurity of 95%. Absolute stereochemistry assigned retrospectively from enantioselective HPLC data of praziquantel synthesised from this compound.
1-(S)-(N-Cyclohexylcarboxamido methyl)-2-(4′-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, (S)-13a
Synthesised
tetrahydroisoquinoline according to the procedure for the racemate in a yield of 86%.
Spectroscopic data ( 1 H NMR) match those of the racemate. 
1-(Nitroethyl)-2-(4′-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline, 9b
To DDQ (3.19 g, 13.1 mmol, 1.1 eq) in nitroethane (100 mL) was added 2-(4′- 
1-Methyl-2-(cyclohexylcarbonyl
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3. Selected NMR spectra Figure S1 . 1 H NMR spectrum (400 MHz) of 10a in MeOD. Figure S2 . 13 C NMR spectrum (100 MHz) of 10a in MeOD. S--20 Figure S5 .
1 H NMR spectrum (400 MHz) of 6a in CDCl 3 . Figure S6 . 13 C NMR spectrum (100 MHz) of 6a in CDCl 3 . 
Design of Experiment procedures
Design of experiments (DoE) is a statistical approach to modeling a response as a function of a number of factors, in order to discover the conditions for an optimal output of the experiment. The Box-Behnken design requires three levels of each of the factors to be defined, and allows an estimate of optimum factor values that is most efficient when they lie within the space defined by the ranges chosen in the design. In the present system it was decided that this could be fulfilled after ballpark conditions were first found through initial, single experiments. Equimolar amounts of amine 8 and (+)-dibenzoyl-Dtartaric acid 8 were used and concentrations giving sufficient (but not complete) crystallization were found. This allowed values for each level to be defined as given in Table S1 . Table S1 . Factor levels and their codes used in the experimental design.
Factors
The design was generated in Matlab (Version R2011a, The Mathworks, USA) and consists of 27 experiments at designated values of each of the factors (Table S2 ). The center point was performed in triplicate to estimate repeatability of the measurements. The response was the yield of recovered amine or the enantiomeric excess. According to the experimental design, individual experiments (0.75 mmol amine and tartaric acid, with concentration being varied through varying the volume of solvent) were conducted in parallel, with start times staggered. Table S2 . Coded factor levels for the experiments in a Box-Behnken design for four factors. The center point is repeated in triplicate. See Table S1 for factors and experimental level values.
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After the allotted time (factor A), any solvent was decanted from the reaction mixture and washed once with 5 mL isopropanol. The resultant crystals were left in the vials used for the experiment and dried in vacuo. The free amine was liberated by dissolving the crystals in saturated sodium hydrogen carbonate solution (20 mL) and extracting into ethyl acetate (20 mL). The organic phase was dried (MgSO 4 ), concentrated under reduced pressure and dried in vacuo, with the mass recorded and a yield calculated. Analysis of the liberated amine was performed by enantioselective HPLC (Chiralcel OD-H column, 0.5 mL flow rate, 0.5 mL injection volume, 60:40:0.1 hexanes:isopropanol:triethylamine) to give the enantiomeric excess.
The statistical model fitted to the responses is a full quadratic including interaction terms. Once the model is obtained it is possible to find values of the factor levels that maximize the response variable. Figure S29 shows the yield as a heat map in the three dimensional space of the time, temperature and solvent ratio, at the three values of concentration of resolving agent. The interpretation of the figures is that increasing the concentration increases the yield, and at the highest concentration (0.2 M), the yield is greatest at the lowest temperature, lowest solvent ratio, and a middle time. The model shows significant interactions among the factors. At higher temperatures a greater solvent ratio is favored, while the optimum is at low temperature and low solvent ratio. Figure S30 is a similar series of graphs for the enantiomeric excess. Though yield and ee were not found to be very compatible in terms of temperature and solvent ratio. While further optimization was possible, the best combination was taken (described in main paper) with enantioenrichment being provided by recrystallization.
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Biological evaluation
Determination of antischistosomal activity on adult Schistosoma mansoni
Adult schistosomes were collected from the hepatic portal system and mesenteric veins of female NMRI mice (n=5, obtained from Harlan Laboratories (Horst, the Netherlands)), seven weeks post subcutaneous infection with ~ 100 cercarcia following standard procedures. 9 The animal work was approved by the local veterinary agency (permit 2070).
Schistosomes were cultured in RPMI 1640 medium (supplemented with 5% inactivated foetal calf serum (iFCS) and 100 U/mL penicillin and 100 µg/mL streptomycin (Invitrogen, Carlsbad, USA)) at 37 °C in an atmosphere of 5% CO 2 until usage.
The test compound was tested in triplicate at various concentrations ranging from 0.31-25.0 µg/mL (25.0, 8.33, 2.78, 0.93 and 0.31 µg/mL) using a DMSO stock solution (conc.
10 mg/mL) and repeated once. The stock solution was diluted in supplemented RPMI1640 medium within 24 flat bottom well plates (BD Falcon, USA) to obtain a final concentration of 25 µg/mL. The lower concentrations were obtained by using a threefold dilution series. Three worms of both sexes were placed into each well containing 2 mL drug and medium. Wells with the highest concentration of DMSO in medium served as controls. After an incubation time of 72 h phenotypes of schistosomes were monitored using the motility scale described by Ramirez et al, and an inverse microscope (Carl Zeiss, Germany, magnification 80x). 10 The IC 50 value was calculated using CompuSyn software (Version 3.0.1, 2007; ComboSyn, Inc) as described before.
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